Biological effects induced by estrogenic activity of lignans

Trends in Food Science and Technology

Volumn 54, Issue , 2016, Pages 186-196

  Kiyama, Ryoiti ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Estrogen assay; Pathway analysis; Phytoestrogen; Receptor crosstalk; Signal transduction

Indexed keywords

ASSAYS; CELL DEATH; CELLS; CROSSTALK; CYTOLOGY; DIAGNOSIS; DISEASE CONTROL; HEALTH RISKS; NEURODEGENERATIVE DISEASES; SIGNAL TRANSDUCTION; SIGNALING;

CELLULAR METABOLISM; ESTROGENIC ACTIVITIES; MECHANISM OF ACTION; MITOGEN ACTIVATED PROTEIN KINASE; PATHWAY ANALYSIS; PHYTOESTROGENES; SIGNALING PATHWAYS; STRUCTURAL CHARACTERISTICS;

CELL SIGNALING;

EID: 84975842804     PISSN: 09242244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tifs.2016.06.007     Document Type: Review

References (163)

1. Abarzua, S., Serikawa, T., Szewczyk, M., Richter, D.U., Piechulla, B., Briese, V., Antiproliferative activity of lignans against the breast carcinoma cell lines MCF 7 and BT 20. Archives of Gynecology & Obstetrics 285:4 (2012), 1145–1151.
2. Adlercreutz, H., Phyto-oestrogens and cancer. Lancet 3:6 (2002), 364–373.
3. Adlercreutz, H., Mazur, W., Phyto-oestrogens and western diseases. Annals of Medicine 29:2 (1997), 95–120.
4. Adolphe, J.L., Whiting, S.J., Juurlink, B.H., Thorpe, L.U., Alcorn, J., Health effects with consumption of the flax lignan secoisolariciresinol diglucoside. British Journal of Nutrition 103:7 (2010), 929–938.
5. Aehle, E., Müller, U., Eklund, P.C., Willför, S.M., Sippl, W., Dräger, B., Lignans as food constituents with estrogen and antiestrogen activity. Phytochemistry 72:18 (2011), 2396–2405.
6. Agarwal, R., Agarwal, C., Ichikawa, H., Singh, R.P., Aggarwal, B.B., Anticancer potential of silymarin: From bench to bed side. Anticancer Research 26:6B (2006), 4457–4498.
7. Allen, K.L., Tschantz, D.R., Awad, K.S., Lynch, W.P., DeLucia, A.L., A plant lignan, 3′-O-methyl-nordihydroguaiaretic acid, suppresses papillomavirus E6 protein function, stabilizes p53 protein, and induces apoptosis in cervical tumor cells. Molecular Carcinogenesis 46:7 (2007), 564–575.
8. Anagnostis, A., Papadopoulos, A.I., Effects of a diet rich in sesame ( Sesamum indicum) pericarp on the expression of oestrogen receptor alpha and oestrogen receptor beta in rat prostate and uterus. British Journal of Nutrition 102:5 (2009), 703–708.
9. Anstead, G.M., Kym, P.R., Benz[a]anthracene diols: Predicted carcinogenicity and structure-estrogen receptor binding affinity relationships. Steroids 60:5 (1995), 383–394.
10. Arnold, S.F., Robinson, M.K., Notides, A.C., Guillette, L.J. Jr., McLachlan, J.A., A yeast estrogen screen for examining the relative exposure of cells to natural and xenoestrogens. Environmental Health Perspectives 104:5 (1996), 544–548.
11. Arora, S., Singh, S., Piazza, G.A., Contreras, C.M., Panyam, J., Singh, A.P., Honokiol: A novel natural agent for cancer prevention and therapy. Current Molecular Medicine 12:10 (2012), 1244–1252.
12. Avtanski, D.B., Nagalingam, A., Bonner, M.Y., Arbiser, J.L., Saxena, N.K., Sharma, D., Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis. Molecular Oncology 8:3 (2014), 565–580.
13. Baker, M.E., What are the physiological estrogens?. Steroids 78:3 (2013), 337–340.
14. Bedell, S., Nachtigall, M., Naftolin, F., The pros and cons of plant estrogens for menopause. Journal of Steroid Biochemistry & Molecular Biology 139 (2014), 225–236.
15. Benzina, S., Harquail, J., Jean, S., Beauregard, A.P., Colquhoun, C.D., Carroll, M., et al. Deoxypodophyllotoxin isolated from Juniperus communis induces apoptosis in breast cancer cells. Anti-cancer Agents in Medicinal Chemistry 15:1 (2015), 79–88.
16. Bhavnani, B.R., Stanczyk, F.Z., Pharmacology of conjugated equine estrogens: Efficacy, safety and mechanism of action. Journal of Steroid Biochemistry & Molecular Biology 142 (2014), 16–29.
17. Borah, A., Paul, R., Choudhury, S., Choudhury, A., Bhuyan, B., Das Talukdar, A., et al. Neuroprotective potential of silymarin against CNS disorders: Insight into the pathways and molecular mechanisms of action. CNS Neuroscience & Therapeutics 19:11 (2013), 847–853.
18. Bryja, V., Sedlácek, J., Zahradnícková, E., Sevcíková, S., Pacherník, J., Soucek, K., et al. Lipoxygenase inhibitors enhance tumor suppressive effects of jun proteins on v-myb-transformed monoblasts BM2. Prostaglandins & Other Lipid Mediators 72:3–4 (2003), 131–145.
19. Brzezinski, A., Debi, A., Phytoestrogens: The “natural” selective estrogen receptor modulators?. European Journal of Obstetrics, Gynecology, & Reproductive Biology 85:1 (1999), 47–51.
20. Canel, C., Moraes, R.M., Dayan, F.E., Ferreira, D., Podophyllotoxin. Phytochemistry 54:2 (2000), 115–120.
21. Cao, J., Chen, J., Xie, L., Wang, J., Feng, C., Song, J., Protective properties of sesamin against fluoride-induced oxidative stress and apoptosis in kidney of carp (Cyprinus carpio) via JNK signaling pathway. Aquatic toxicology 167 (2015), 180–190.
22. Caron, J.M., Posttranslational modification of tubulin by palmitoylation: I. In vivo and cell-free studies. Molecular Biology of the Cell 8:4 (1997), 621–636.
23. Carreau, C., Flouriot, G., Bennetau-Pelissero, C., Potier, M., Enterodiol and enterolactone, two major diet-derived polyphenol metabolites have different impact on ERalpha transcriptional activation in human breast cancer cells. Journal of Steroid Biochemistry & Molecular Biology 110:1–2 (2008), 176–185.
24. Chang, L.C., Gills, J.J., Bhat, K.P., Luyengi, L., Farnsworth, N.R., Pezzuto, J.M., et al. Activity-guided isolation of constituents of Cerbera manghas with antiproliferative and antiestrogenic activities. Bioorganic & Medicinal Chemistry Letters 10:21 (2000), 2431–2434.
25. Chao, Y.Y., Jan, C.R., Ko, Y.C., Chen, J.J., Jiann, B.P., Lu, Y.C., et al. Effect of lignans isolated from Hernandia nymphaeifolia on estrogenic compounds-induced calcium mobilization in human neutrophils. Life Sciences 70:26 (2002), 3109–3121.
26. Choi, J.Y., Hong, W.G., Cho, J.H., Kim, E.M., Kim, J., Jung, C.H., et al. Podophyllotoxin acetate triggers anticancer effects against non-small cell lung cancer cells by promoting cell death via cell cycle arrest, ER stress and autophagy. International Journal of Oncology 47:4 (2015), 1257–1265.
27. Cho, J.Y., Park, J., Kim, P.S., Yoo, E.S., Baik, K.U., Park, M.H., Savinin, a lignan from Pterocarpus santalinus inhibits tumor necrosis factor-alpha production and T cell proliferation. Biological & Pharmaceutical Bulletin 24:2 (2001), 167–171.
28. Christianson-Heiska, I., Isomaa, B., The use of primary hepatocytes from brown trout (Salmo trutta lacustris) and the fish cell lines RTH-149 and ZF-L for in vitro screening of (anti)estrogenic activity of wood extractives. Toxicology In Vitro 22:3 (2008), 589–597.
29. Chunlian, W., Heyong, W., Jia, X., Jie, H., Xi, C., Gentao, L., Magnolol inhibits tumor necrosis factor-α-induced ICAM-1 expression via suppressing NF-κB and MAPK signaling pathways in human lung epithelial cells. Inflammation 37:6 (2014), 1957–1967.
30. Cosentino, M., Marino, F., Ferrari, M., Rasini, E., Bombelli, R., Luini, A., et al. Estrogenic activity of 7-hydroxymatairesinol potassium acetate (HMR/lignan) from Norway spruce (Picea abies) knots and of its active metabolite enterolactone in MCF-7 cells. Pharmacological Research 56:2 (2007), 140–147.
31. Cui, Y., Lu, C., Liu, L., Sun, D., Yao, N., Tan, S., et al. Reactivation of methylation-silenced tumor suppressor gene p16INK4a by nordihydroguaiaretic acid and its implication in G1 cell cycle arrest. Life Sciences 82:5–6 (2008), 247–255.
32. Damdimopoulou, P., Nurmi, T., Salminen, A., Damdimopoulos, A.E., Kotka, M., van der Saag, P., et al. A single dose of enterolactone activates estrogen signaling and regulates expression of circadian clock genes in mice. Journal of Nutrition 141:9 (2011), 1583–1589.
33. Dar, A.A., Arumugam, N., Lignans of sesame: Purification methods, biological activities and biosynthesis–a review. Bioorganic Chemistry 50 (2013), 1–10.
34. Davis-Searles, P.R., Nakanishi, Y., Kim, N.C., Graf, T.N., Oberlies, N.H., Wani, M.C., et al. Milk thistle and prostate cancer: Differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. Cancer Research 65:10 (2005), 4448–4457.
35. Deep, G., Agarwal, R., Antimetastatic efficacy of silibinin: Molecular mechanisms and therapeutic potential against cancer. Cancer Metastasis Reviews 29:3 (2010), 447–463.
36. Deyama, T., Nishibe, S., Pharmacological properties of lignans. Heitner, C., Dimmel, D., Schmidt, J.A., (eds.) Lignin and lignans: Advances in chemistry, 2010, CRC Press, Boca Raton, FL, 585–629.
37. Dixon, R.A., Phytoestrogens. Annual Review of Plant Biology 55 (2004), 225–261.
38. During, A., Debouche, C., Raas, T., Larondelle, Y., Among plant lignans, pinoresinol has the strongest antiinflammatory properties in human intestinal Caco-2 cells. Journal of Nutrition 142:10 (2012), 1798–1805.
39. Fang, H., Tong, W., Shi, L.M., Blair, R., Perkins, R., Branham, W., et al. Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chemical Research in Toxicology 14:3 (2001), 280–294.
40. Fokialakis, N., Magiatis, P., Mitaku, S., Pratsinis, H., Tillequin, F., Estrogenic activity of phenylpropanoids from Sarcomelicope megistophylla and structure determination of a new norneolignan. Planta Medica 69:6 (2003), 566–568.
41. Fujimoto, N., Kohta, R., Kitamura, S., Estrogenic activity of an antioxidant, nordihydroguaiaretic acid (NDGA). Life Sciences 74:11 (2004), 1417–1425.
42. Gazák, R., Walterová, D., Kren, V., Silybin and silymarin–new and emerging applications in medicine. Current Medicinal Chemistry 14:3 (2007), 315–338.
43. Guerrero, E., Abad, A., Montenegro, G., Del Olmo, E., López-Pérez, J.L., San Feliciano, A., Analgesic and anti-inflammatory activity of podophyllotoxin derivatives. Pharmaceutical Biology 51:5 (2013), 566–572.
44. Gu, Y., Sun, X.X., Ye, J.M., He, L., Yan, S.S., Zhang, H.H., et al. Arctigenin alleviates ER stress via activating AMPK. Acta Pharmacologica Sinica 33:7 (2012), 941–952.
45. Hartley, R.M., Peng, J., Fest, G.A., Dakshanamurthy, S., Frantz, D.E., Brown, M.L., et al. Polygamain, a new microtubule depolymerizing agent that occupies a unique pharmacophore in the colchicine site. Molecular Pharmacology 81:3 (2012), 431–439.
46. Hayashi, K., Narutaki, K., Nagaoka, Y., Hayashi, T., Uesato, S., Therapeutic effect of arctiin and arctigenin in immunocompetent and immunocompromised mice infected with influenza A virus. Biological & Pharmaceutical Bulletin 33:7 (2010), 1199–1205.
47. He, C., Chen, X., Zhao, C., Qie, Y., Yan, Z., Zhu, X., Eleutheroside E ameliorates arthritis severity in collagen-induced arthritis mice model by suppressing inflammatory cytokine release. Inflammation 37:5 (2014), 1533–1543.
48. Hien, T.T., Ki, S.H., Yang, J.W., Oh, W.K., Kang, K.W., Nectandrin B suppresses the expression of adhesion molecules in endothelial cells: Role of AMP-activated protein kinase activation. Food & Chemical Toxicology 66 (2014), 286–294.
49. Hien, T.T., Oh, W.K., Nguyen, P.H., Oh, S.J., Lee, M.Y., Kang, K.W., Nectandrin B activates endothelial nitric-oxide synthase phosphorylation in endothelial cells: Role of the AMP-activated protein kinase/estrogen receptor α/phosphatidylinositol 3-kinase/Akt pathway. Molecular Pharmacology 80:6 (2011), 1166–1178.
50. Hillerns, P.I., Zu, Y., Fu, Y.J., Wink, M., Binding of phytoestrogens to rat uterine estrogen receptors and human sex hormone-binding globulins. Zeitschrift für Naturforschung C 60:7–8 (2005), 649–656.
51. Hou, R.C., Wu, C.C., Yang, C.H., Jeng, K.C., Protective effects of sesamin and sesamolin on murine BV-2 microglia cell line under hypoxia. Neuroscience Letters 367:1 (2004), 10–13.
52. Hsieh, C.C., Kuo, C.H., Kuo, H.F., Chen, Y.S., Wang, S.L., Chao, D., et al. Sesamin suppresses macrophage-derived chemokine expression in human monocytes via epigenetic regulation. Food & Function 5:10 (2014), 2494–2500.
53. Hsieh, C.J., Kuo, P.L., Hsu, Y.C., Huang, Y.F., Tsai, E.M., Hsu, Y.L., Arctigenin, a dietary phytoestrogen, induces apoptosis of estrogen receptor-negative breast cancer cells through the ROS/p38 MAPK pathway and epigenetic regulation. Free Radical Biology & Medicine 67 (2014), 159–170.
54. Huang, Z., Fang, Z., Zhen, H., Zhou, L., Amin, H.M., Shi, P., Inhibition of type I insulin-like growth factor receptor tyrosine kinase by picropodophyllin induces apoptosis and cell cycle arrest in T lymphoblastic leukemia/lymphoma. Leukemia & Lymphoma 55:8 (2014), 1876–1883.
55. Jin, J.S., Lee, J.H., Hattori, M., Ligand binding affinities of arctigenin and its demethylated metabolites to estrogen receptor alpha. Molecules 18:1 (2013), 1122–1127.
56. Jin, D.Q., Lim, C.S., Hwang, J.K., Ha, I., Han, J.S., Anti-oxidant and anti-inflammatory activities of macelignan in murine hippocampal cell line and primary culture of rat microglial cells. Biochemical & Biophysical Research Communications 331:4 (2005), 1264–1269.
57. Jungbauer, A., Medjakovic, S., Phytoestrogens and the metabolic syndrome. Journal of Steroid Biochemistry and Molecular Biology 139 (2014), 277–289.
58. Jung, C.H., Kim, H., Ahn, J., Jung, S.K., Um, M.Y., Son, K.H., et al. Anthricin isolated from anthriscus sylvestris (L.) Hoffm. Inhibits the growth of breast Cancer cells by inhibiting Akt/mTOR signaling, and its apoptotic effects are enhanced by autophagy inhibition. Evidence-based Complementary & Alternative Medicine, 2013, 2013, 385219.
59. Kato, T., Hirose, M., Takahashi, S., Hasegawa, R., Kohno, T., Nishibe, S., et al. Effects of the lignan, arctiin, on 17-beta ethinyl estradiol promotion of preneoplastic liver cell foci development in rats. Anticancer Research 18:2A (1998), 1053–1057.
60. Katzenellenbogen, J.A., The structural pervasiveness of estrogenic activity. Environmental Health Perspectives 103:Suppl 7 (1995), 99–101.
61. Kiem, P.V., Tri, M.D., Tuong, L.V.D., Tung, N.H., Hanh, N.N., Quang, T.H., et al. Chemical constituents from the leaves of Manglietia phuthoensis and their effects on osteoblastic MC3T3-E1 cells. Chemical & Pharmaceutical Bulletin 56:9 (2008), 1270–1275.
62. Kim, S.J., Min, H.Y., Lee, E.J., Kim, Y.S., Bae, K., Kang, S.S., et al. Growth inhibition and cell cycle arrest in the G0/G1 by schizandrin, a dibenzocyclooctadiene lignan isolated from Schisandra chinensis, on T47D human breast cancer cells. Phytotherapy Research 24:2 (2010), 193–197.
63. Kim, J.Y., Hwang, J.H., Cha, M.R., Yoon, M.Y., Son, E.S., Tomida, A., et al. Arctigenin blocks the unfolded protein response and shows therapeutic antitumor activity. Journal of Cellular Physiology 224:1 (2010), 33–40.
64. Kim, J.H., Lee, J.K., Sesamolin enhances NK cell lysis activity by increasing the expression of NKG2D ligands on Burkitt's lymphoma cells. International Immunopharmacology 28:2 (2015), 977–984.
65. Kiyama, R., Endocrine disruptor actions through receptor crosstalk. Environmental Biotechnology, 2016 (in press).
66. Kiyama, R., Wada-Kiyama, Y., Estrogenic endocrine disruptors: Molecular mechanisms of action. Environment International 83 (2015), 11–40.
67. Kiyama, R., Zhu, Y., DNA microarray-based gene expression profiling of estrogenic chemicals. Cellular & Molecular Life Sciences 71:11 (2014), 2065–2082.
68. Kumar, R., Silakari, O., Kaur, M., Lignans as anticancer agents. 2012, LAP Lambert Academic Publishing, Germany.
69. Kummer, V., Mašková, J., Canderle, J., Zralý, Z., Neča, J., Machala, M., Estrogenic effects of silymarin in ovariectomized rats. Veterinary Medicine (Praha) 46:1 (2001), 17–23.
70. Lahaie-Collins, V., Bournival, J., Plouffe, M., Carange, J., Martinoli, M.G., Sesamin modulates tyrosine hydroxylase, superoxide dismutase, catalase, inducible NO synthase and interleukin-6 expression in dopaminergic cells under MPP+-induced oxidative stress. Oxidative Medicine & Cellular Longevity 1:1 (2008), 54–62.
71. Lam, P.Y., Ko, K.M., Schisandrin B as a hormetic agent for preventing age-related neurodegenerative diseases. Oxidative Medicine & Cellular Longevity, 2012, 2012, 250825.
72. Lampe, J.W., Isoflavonoid and lignan phytoestrogens as dietary biomarkers. Journal of Nutrition 133:Suppl 3 (2003), 956S–964S.
73. Leclercq, G., de Cremoux, P., This, P., Jacquot, Y., Lack of sufficient information on the specificity and selectivity of commercial phytoestrogens preparations for therapeutic purposes. Maturitas 68:1 (2011), 56–64.
74. Lee, C.H., Jang, Y.S., Her, S.J., Moon, Y.M., Baek, S.J., Eling, T., Nordihydroguaiaretic acid, an antioxidant, inhibits transforming growth factor-beta activity through the inhibition of Smad signaling pathway. Experimental Cell Research 289:2 (2003), 335–341.
75. Lee, J.H., Jang, E.J., Seo, H.L., Ku, S.K., Lee, J.R., Shin, S.S., et al. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway. Chemico-Biological Interactions 224C (2014), 58–67.
76. Lee, M.A., Kim, W.K., Park, H.J., Kang, S.S., Lee, S.K., Anti-proliferative activity of hydnocarpin, a natural lignan, is associated with the suppression of Wnt/β-catenin signaling pathway in colon cancer cells. Bioorganic & Medicinal Chemistry Letters 23:20 (2013), 5511–5514.
77. Lee, M.K., Yang, H., Ma, C.J., Kim, Y.C., Stimulatory activity of lignans from Machilus thunbergii on osteoblast differentiation. Biological & Pharmaceutical Bulletin 30:4 (2007), 814–817.
78. Lee, S., Yoo, H.H., Piao, X.L., Kim, J.S., Kang, S.S., Shin, K.H., Anti-estrogenic activity of lignans from Acanthopanax chiisanensis root. Archives of Pharmacal Research 28:2 (2005), 186–189.
79. Li, X.Y., Bioactivity of neolignans from fructus Schizandrae. Memórias do Instituto Oswaldo Cruz 86:Suppl 2 (1991), 31–37.
80. Li, H.B., Gao, J.M., Ying, X.X., Wang, S.P., Li, J.C., Protective effect of magnolol on TBHP-induced injury in H460 cells partially via a p53 dependent mechanism. Archives of Pharmacal Research 30:7 (2007), 850–857.
81. Liu, M.M., Huang, Y., Wang, J., Developing phytoestrogens for breast cancer prevention. Anti-cancer Agents in Medicinal Chemistry 12:10 (2012), 1306–1313.
82. Liu, H., Sui, X., Li, X., Li, Y., Lyoniresinol inhibits melanogenic activity through the induction of microphthalmia-associated transcription factor and extracellular receptor kinase activation. Molecular & Cellular Biochemistry 373:1–2 (2013), 211–216.
83. Liu, H.W., Yu, X.Z., Padula, D., Pescitelli, G., Lin, Z.W., Wang, F., et al. Lignans from schisandra sphenathera rehd. Et wils. And semisynthetic schisantherin A analogues: Absolute configuration, and their estrogenic and anti-proliferative activity. European Journal of Medicinal Chemistry 59 (2013), 265–273.
84. Liu, H., Zang, C., Emde, A., Planas-Silva, M.D., Rosche, M., Kühnl, A., et al. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. European Journal of Pharmacology 591:1–3 (2008), 43–51.
85. Li, L., Zeng, J., Gao, Y., He, D., Targeting silibinin in the antiproliferative pathway. Expert Opinion on Investigational Drugs 19:2 (2010), 243–255.
86. Li, X., Zhao, X., Xu, X., Mao, X., Liu, Z., Li, H., et al. Schisantherin A recovers Aβ-induced neurodegeneration with cognitive decline in mice. Physiology & Behavior 132 (2014), 10–16.
87. Lóránd, T., Vigh, E., Garai, J., Hormonal action of plant derived and anthropogenic non-steroidal estrogenic compounds: Phytoestrogens and xenoestrogens. Current Medicinal Chemistry 17:30 (2010), 3542–3574.
88. Luecha, P., Umehara, K., Miyase, T., Noguchi, H., Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata. Journal of Natural Products 72:11 (2009), 1954–1959.
89. Lü, J.M., Nurko, J., Weakley, S.M., Jiang, J., Kougias, P., Lin, P.H., et al. Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: An update. Medical Science Monitor 16:5 (2010), RA93–RA100.
90. MacRae, W.D., Towers, G.H., Biological activities of lignans. Phytochemistry 23:6 (1984), 1207–1220.
91. Ma, L., Gong, X., Kuang, G., Jiang, R., Chen, R., Wan, J., Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice. Biochemical & Biophysical Research Communications 461:2 (2015), 230–236.
92. Ma, J., Hwang, Y.K., Cho, W.H., Han, S.H., Hwang, J.K., Han, J.S., Macelignan attenuates activations of mitogen-activated protein kinases and nuclear factor kappa B induced by lipopolysaccharide in microglial cells. Biological & Pharmaceutical Bulletin 32:6 (2009), 1085–1090.
93. Mann, V., Huber, C., Kogianni, G., Collins, F., Noble, B., The antioxidant effect of estrogen and selective estrogen receptor modulators in the inhibition of osteocyte apoptosis in vitro. Bone 40:3 (2007), 674–684.
94. Mazur, W., Phytoestrogen content in foods. Baillière's Clinical Endocrinology & Metabolism 12:4 (1998), 729–742.
95. Mazur, W.M., Duke, J.A., Wähälä, K., Rasku, S., Adlercreutz, H., Isoflavonoids and lignans in legumes: Nutritional and health aspects in humans. Journal of Nutritional Biochemistry 9:4 (1998), 193–200.
96. Mesa-Siverio, D., Machín, R.P., Estévez-Braun, A., Ravelo, A.G., Lock, O., Structure and estrogenic activity of new lignans from Iryanthera lancifolia. Bioorganic & Medicinal Chemistry 16:6 (2008), 3387–3394.
97. Miksicek, R.J., Estrogenic flavonoids: Structural requirements for biological activity. Proceedings of the Society for Experimental Biology & Medicine 208:1 (1995), 44–50.
98. Milder, I.E., Arts, I.C., van de Putte, B., Venema, D.P., Hollman, P.C., Lignan contents of Dutch plant foods: A database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. British Journal of Nutrition 93:3 (2005), 393–402.
99. Minami, E., Taki, M., Takaishi, S., Iijima, Y., Tsutsumi, S., Akiyama, T., Stereochemistry of cis- and trans-hinokiresinol and their estrogen-like activity. Chemical & Pharmaceutical Bulletin 48:3 (2000), 389–392.
100. Min, B., Lee, H., Song, J.H., Han, M.J., Chung, J., Arctiin inhibits adipogenesis in 3T3-L1 cells and decreases adiposity and body weight in mice fed a high-fat diet. Nutrition Research & Practice 8:6 (2014), 655–661.
101. Moon, S.S., Rahman, A.A., Kim, J.Y., Kee, S.H., Hanultarin, a cytotoxic lignan as an inhibitor of actin cytoskeleton polymerization from the seeds of Trichosanthes kirilowii. Bioorganic & Medicinal Chemistry 16:15 (2008), 7264–7269.
102. Moss, G.P., Nomenclature of lignans and neolignans (IUPAC Recommendations 2000). Pure& Applied Chemistry 72:8 (2000), 1493–1523.
103. Mousavi, Y., Adlercreutz, H., Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture. Journal of Steroid Biochemistry & Molecular Biology 41:3–8 (1992), 615–619.
104. Nejati-Koshki, K., Zarghami, N., Pourhassan-Moghaddam, M., Rahmati-Yamchi, M., Mollazade, M., Nasiri, M., et al. Inhibition of leptin gene expression and secretion by silibinin: Possible role of estrogen receptors. Cytotechnology 64:6 (2012), 719–726.
105. Nishikawa, J., Saito, K., Goto, J., Dakeyama, F., Matsuo, M., Nishihara, T., New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. Toxicology & Applied Pharmacology 154:1 (1999), 76–83.
106. Ohta, R., Takagi, A., Ohmukai, H., Marumo, H., Ono, A., Matsushima, Y., et al. Ovariectomized mouse uterotrophic assay of 36 chemicals. Journal of Toxicological Sciences 37:5 (2012), 879–889.
107. Ososki, A.L., Kennelly, E.J., Phytoestrogens: A review of the present state of research. Phytotherapy Research 17:8 (2003), 845–869.
108. Ou, J.P., Lin, H.Y., Su, K.Y., Yu, S.L., Tseng, I.H., Chen, C.J., et al. Potential therapeutic role of Z-isochaihulactone in lung cancer through induction of apoptosis via Notch signaling. Evidence-based Complementary & Alternative Medicine, 2012, 2012, 809204.
109. Panossian, A., Hamm, R., Kadioglu, O., Wikman, G., Efferth, T., Synergy and antagonism of active constituents of ADAPT-232 on transcriptional level of metabolic regulation of isolated neuroglial cells. Frontiers in Neuroscience, 7, 2013, 16.
110. Park, E.J., Min, H.Y., Chung, H.J., Hong, J.Y., Kang, Y.J., Hung, T.M., et al. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. Cancer Letters 277:2 (2009), 133–140.
111. Park, S.Y., Park, S.J., Park, T.G., Rajasekar, S., Lee, S.J., Choi, Y.W., Schizandrin C exerts anti-neuroinflammatory effects by upregulating phase II detoxifying/antioxidant enzymes in microglia. International Immunopharmacology 17:2 (2013), 415–426.
112. Paruthiyil, S., Cvoro, A., Zhao, X., Wu, Z., Sui, Y., Staub, R.E., et al. Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists. PloS One, 4(7), 2009, e6271.
113. Pathak, N., Rai, A.K., Kumari, R., Bhat, K.V., Value addition in sesame: A perspective on bioactive components for enhancing utility and profitability. Pharmacognosy Reviews 8:16 (2014), 147–155.
114. Peuhu, E., Paul, P., Remes, M., Holmbom, T., Eklund, P., Sjöholm, R., et al. The antitumor lignan Nortrachelogenin sensitizes prostate cancer cells to TRAIL-induced cell death by inhibition of the Akt pathway and growth factor signaling. Biochemical Pharmacology 86:5 (2013), 571–583.
115. Pianjing, P., Thiantanawat, A., Rangkadilok, N., Watcharasit, P., Mahidol, C., Satayavivad, J., Estrogenic activities of sesame lignans and their metabolites on human breast cancer cells. Journal of Agricultural & Food Chemistry 59:1 (2011), 212–221.
116. Pisha, E., Pezzuto, J.M., Cell-based assay for the determination of estrogenic and anti-estrogenic activities. Methods in Cell Science 19 (1997), 37–43.
117. Plísková, M., Vondrácek, J., Kren, V., Gazák, R., Sedmera, P., Walterová, D., et al. Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation. Toxicology 215:1–2 (2005), 80–89.
118. Price, K.R., Fenwick, G.R., Naturally occurring oestrogens in foods–a review. Food Additives & Contaminants 2:2 (1985), 73–106.
119. Pullela, S.V., Takamatsu, S., Khan, S.I., Khan, I.A., Isolation of lignans and biological activity studies of Ephedra viridis. Planta Medica 71:8 (2005), 789–791.
120. Raja, S.M., Chen, S., Yue, P., Acker, T.M., Lefkove, B., Arbiser, J.L., et al. The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis. Molecular Cancer Therapeutics 7:7 (2008), 2212–2223.
121. Saarinen, N.M., Penttinen, P.E., Smeds, A.I., Hurmerinta, T.T., Mäkelä, S.I., Structural determinants of plant lignans for growth of mammary tumors and hormonal responses in vivo. Journal of Steroid Biochemistry & Molecular Biology 93:2–5 (2005), 209–219.
122. Saarinen, N.M., Wärri, A., Airio, M., Smeds, A., Mäkelä, S., Role of dietary lignans in the reduction of breast cancer risk. Molecular Nutrition & Food Research 51:7 (2007), 857–866.
123. Saarinen, N.M., Wärri, A., Mäkelä, S.I., Eckerman, C., Reunanen, M., Ahotupa, M., et al. Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutrition & Cancer 36:2 (2000), 207–216.
124. Saggar, J.K., Chen, J., Corey, P., Thompson, L.U., The effect of secoisolariciresinol diglucoside and flaxseed oil, alone and in combination, on MCF-7 tumor growth and signaling pathways. Nutrition & Cancer 62:4 (2010), 533–542.
125. Sang, C.Y., Xu, X.H., Qin, W.W., Liu, J.F., Hui, L., Chen, S.W., DPMA, a deoxypodophyllotoxin derivative, induces apoptosis and anti-angiogenesis in non-small cell lung cancer A549 cells. Bioorganic & Medicinal Chemistry Letters 23:24 (2013), 6650–6655.
126. Satake, H., Ono, E., Murata, J., Recent advances in the metabolic engineering of lignan biosynthesis pathways for the production of transgenic plant-based foods and supplements. Journal of Agricultural & Food Chemistry 61:48 (2013), 11721–11729.
127. Sathyamoorthy, N., Wang, T.T., Phang, J.M., Stimulation of pS2 expression by diet-derived compounds. Cancer Research 54:4 (1994), 957–961.
128. Sa, F., Zhang, L.Q., Chong, C.M., Guo, B.J., Li, S., Zhang, Z.J., et al. Discovery of novel anti-parkinsonian effect of schisantherin A in in vitro and in vivo. Neuroscience Letters 593 (2015), 7–12.
129. Schultz, T.W., Sinks, G.D., Cronin, M.T., Structure-activity relationships for gene activation oestrogenicity: Evaluation of a diverse set of aromatic chemicals. Environmental Toxicology 17:1 (2002), 14–23.
130. Seidlová-Wuttke, D., Becker, T., Christoffel, V., Jarry, H., Wuttke, W., Silymarin is a selective estrogen receptor beta (ERbeta) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats. Journal of Steroid Biochemistry & Molecular Biology 86:2 (2003), 179–188.
131. Shen, J.L., Man, K.M., Huang, P.H., Chen, W.C., Chen, D.C., Cheng, Y.W., et al. Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders. Molecules 15:9 (2010), 6452–6465.
132. Shim, K.W., Xi, G., Farnell, B.M., Kim, D.S., Tsurubuchi, T., Tomita, T., et al. Epigenetic modification after inhibition of IGF-1R signaling in human central nervous system atypical teratoid rhabdoid tumor (AT/RT). Child's Nervous System 29:8 (2013), 1245–1251.
133. Shyur, L.F., Lee, S.H., Chang, S.T., Lo, C.P., Kuo, Y.H., Wang, S.Y., Taiwanin A inhibits MCF-7 cancer cell activity through induction of oxidative stress, upregulation of DNA damage checkpoint kinases, and activation of p53 and FasL/Fas signaling pathways. Phytomedicine 18:1 (2010), 16–24.
134. Singh, R.P., Agarwal, R., A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer. Mutation Research 555:1–2 (2004), 21–32.
135. Singh, R.P., Agarwal, R., Cosmeceuticals and silibinin. Clinics in Dermatology 27:5 (2009), 479–484.
136. Sonneveld, E., Jansen, H.J., Riteco, J.A., Brouwer, A., van der Burg, B., Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. Toxicological Sciences 83:1 (2005), 136–148.
137. Soto, A.M., Sonnenschein, C., Chung, K.L., Fernandez, M.F., Olea, N., Serrano, F.O., The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environmental Health Perspectives 103:Suppl 7 (1995), 113–122.
138. Suzuki, S., Umezawa, T., Biosynthesis of lignans and norlignans. Journal of Wood Science 53:4 (2007), 273–284.
139. Takeuchi, S., Takahashi, T., Sawada, Y., Iida, M., Matsuda, T., Kojima, H., Comparative study on the nuclear hormone receptor activity of various phytochemicals and their metabolites by reporter gene assays using Chinese hamster ovary cells. Biological & Pharmaceutical Bulletin 32:2 (2009), 195–202.
140. Talaei, M., Pan, A., Role of phytoestrogens in prevention and management of type 2 diabetes. World Journal of Diabetes 6:2 (2015), 271–283.
141. Tatewaki, N., Nishida, H., Yoshida, M., Ando, H., Kondo, S., Sakamaki, T., et al. Differential effect of schisandrin B stereoisomers on ATR-mediated DNA damage checkpoint signaling. Journal of Pharmacological Sciences 122:2 (2013), 138–148.
142. Tominaga, S., Sugahara, T., Nishimoto, S., Yamawaki, M., Nakashima, Y., Kishida, T., et al. The effect of secoisolariciresinol on 3T3-L1 adipocytes and the relationship between molecular structure and activity. Bioscience, Biotechnology, &Biochemistry 73:1 (2009), 35–39.
143. Truan, J.S., Chen, J.M., Thompson, L.U., Comparative effects of sesame seed lignan and flaxseed lignan in reducing the growth of human breast tumors (MCF-7) at high levels of circulating estrogen in athymic mice. Nutrition & Cancer 64:1 (2012), 65–71.
144. Usui, T., Pharmaceutical prospects of phytoestrogens. Endocrine Journal 53:1 (2006), 7–20.
145. Wang, L.Q., Mammalian phytoestrogens: Enterodiol and enterolactone. Journal of Chromatography B 777:1–2 (2002), 289–309.
146. Wang, C., Kurzer, M.S., Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutrition & Cancer 28:3 (1997), 236–247.
147. Wang, C., Mäkelä, T., Hase, T., Adlercreutz, H., Kurzer, M.S., Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. Journal of Steroid Biochemistry & Molecular Biology 50:3–4 (1994), 205–212.
148. Wang, Y., Yang, Z., Zhao, X., Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells. Toxicology Mechanisms &Methods 20:5 (2010), 234–241.
149. Welshons, W.V., Murphy, C.S., Koch, R., Calaf, G., Jordan, V.C., Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol. Breast Cancer Research & Treatment 10:2 (1987), 169–175.
150. Woodbury, A., Yu, S.P., Wei, L., García, P., Neuro-modulating effects of honokiol: A review. Frontiers in Neurology, 4, 2013, 130.
151. Wu, X.L., Liou, C.J., Li, Z.Y., Lai, X.Y., Fang, L.W., Huang, W.C., Sesamol suppresses the inflammatory response by inhibiting NF-κB/MAPK activation and upregulating AMP kinase signaling in RAW 264. Inflammation Research 64:8 (2015), 577–588.
152. Xiao, H.H., Gao, Q.G., Ho, M.X., Zhang, Y., Wong, K.C., Dai, Y., et al. An 8-O-4′ norlignan exerts oestrogen-like actions in osteoblastic cells via rapid nongenomic ER signaling pathway. Journal of Ethnopharmacology 170 (2015), 39–49.
153. Xie, L.H., Ahn, E.M., Akao, T., Abdel-Hafez, A.A., Nakamura, N., Hattori, M., Transformation of arctiin to estrogenic and antiestrogenic substances by human intestinal bacteria. Chemical & Pharmaceutical Bulletin 51:4 (2003), 378–384.
154. Yang, X., Cui, W., Yu, S., Xu, C., Chen, G., Gu, A., et al. A synthetic dl-nordihydroguaiaretic acid (Nordy), inhibits angiogenesis, invasion and proliferation of glioma stem cells within a zebrafish xenotransplantation model. PloS One, 9(1), 2014, e85759.
155. Yang, T.M., Guo, S.F., Chen, C.R., Zhang, X.Y., Li, W.G., Anti-osteosarcoma effects and mechanisms of 4-O-amino-phenol-4′-demethylepipodophyllotoxin ether. Journal of Pharmacy & Pharmacology 60:2 (2008), 179–188.
156. Yang, S., Ma, J., Xiao, J., Lv, X., Li, X., Yang, H., et al. Arctigenin anti-tumor activity in bladder cancer T24 cell line through induction of cell-cycle arrest and apoptosis. Anatomical Record 295:8 (2012), 1260–1266.
157. Yao, X., Li, G., Lü, C., Xu, H., Yin, Z., Arctigenin promotes degradation of inducible nitric oxide synthase through CHIP-associated proteasome pathway and suppresses its enzyme activity. International Immunopharmacology 14:2 (2012), 138–144.
158. Yen, Y.T., Wu, R.T., Tang, S.J., Wang, F.F., Expression of c-myc proto-oncogene during podophyllotoxin induced IW32 erythroleukemia cell differentiation. Biochemical & Biophysical Research Communications 179:3 (1991), 1241–1246.
159. Yoo, H.H., Park, J.H., Kwon, S.W., An anti-estrogenic lignan glycoside, tracheloside, from seeds of Carthamus tinctorius. Bioscience, Biotechnology, & Biochemistry 70:11 (2006), 2783–2785.
160. Yousefi, M., Ghaffari, S.H., Zekri, A., Hassani, S., Alimoghaddam, K., Ghavamzadeh, A., Silibinin induces apoptosis and inhibits proliferation of estrogen receptor (ER)-negative breast carcinoma cells through suppression of nuclear factor kappa B activation. Archives of Iranian Medicine 17:5 (2014), 366–371.
161. Zavodovskaya, M., Campbell, M.J., Maddux, B.A., Shiry, L., Allan, G., Hodges, L., et al. Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells. Journal of Cellular Biochemistry 103:2 (2008), 624–635.
162. Zhao, M., Zheng, S., Yang, J., Wu, Y., Ren, Y., Kong, X., et al. Suppression of TGF-β1/Smad signaling pathway by sesamin contributes to the attenuation of myocardial fibrosis in spontaneously hypertensive rats. PloS One, 10(3), 2015, e0121312.
163. Zheng, N., Zhang, P., Huang, H., Liu, W., Hayashi, T., Zang, L., et al. ERα down-regulation plays a key role in silibinin-induced autophagy and apoptosis in human breast cancer MCF-7 cells. Journal of Pharmacological Sciences 128:3 (2015), 97–107.